These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 15325613

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, DuBois RN.
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [Abstract] [Full Text] [Related]

  • 3. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L, Chen W, Xie X, He Y, Bai X.
    Exp Oncol; 2008 Mar 02; 30(1):42-51. PubMed ID: 18438340
    [Abstract] [Full Text] [Related]

  • 5. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS.
    Clin Cancer Res; 2001 May 02; 7(5):1410-8. PubMed ID: 11350912
    [Abstract] [Full Text] [Related]

  • 6. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T, Kitajima M.
    Anticancer Res; 2003 May 02; 23(1A):245-9. PubMed ID: 12680220
    [Abstract] [Full Text] [Related]

  • 7. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A.
    Clin Cancer Res; 2003 May 02; 9(5):1885-97. PubMed ID: 12738747
    [Abstract] [Full Text] [Related]

  • 8. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Ding XZ, Tong WG, Adrian TE.
    Anticancer Res; 2000 May 02; 20(4):2625-31. PubMed ID: 10953335
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M.
    Lab Invest; 1999 Dec 02; 79(12):1469-77. PubMed ID: 10616198
    [Abstract] [Full Text] [Related]

  • 10. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC, McBride WH, Chen SM, Lee KF, Hwang TZ, Jung SM, Shau H, Liao SK, Hong JH, Chen MF.
    Head Neck; 2005 Jun 02; 27(6):503-12. PubMed ID: 15772955
    [Abstract] [Full Text] [Related]

  • 11. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM.
    Cancer Res; 2000 Sep 01; 60(17):4926-31. PubMed ID: 10987308
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 14. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ.
    Int J Oncol; 2003 Jul 15; 23(1):113-9. PubMed ID: 12792783
    [Abstract] [Full Text] [Related]

  • 15. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M.
    Int J Oncol; 2003 Apr 15; 22(4):757-63. PubMed ID: 12632065
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
    Yao M, Lam EC, Kelly CR, Zhou W, Wolfe MM.
    Br J Cancer; 2004 Feb 09; 90(3):712-9. PubMed ID: 14760389
    [Abstract] [Full Text] [Related]

  • 17. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec 09; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
    Ferrario A, Von Tiehl K, Wong S, Luna M, Gomer CJ.
    Cancer Res; 2002 Jul 15; 62(14):3956-61. PubMed ID: 12124326
    [Abstract] [Full Text] [Related]

  • 20. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.
    Kim SJ, Seo JH, Lee YJ, Yoon JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    Oncology; 2005 Jul 15; 68(2-3):204-11. PubMed ID: 16015035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.